But in addition to following your psoriatic arthritis medication regimen, adding these steps to your overall management plan ...

Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on ...

Researchers identified 3 distinct PsA phenotype clusters, emphasizing the importance of PsO severity in treatment decision making.

Explore the gap between patient and clinician perspectives in psoriatic arthritis care. Learn how priorities differ and why ...

The NHS says psoriatic arthritis is a long-term condition that causes joint pain, swelling and stiffness. Medicines can help treat the symptoms. Some people with the skin condition psoriasis may ...